Anders specialises in strategic collaborations in the pharmaceutical industry and in regulatory law. He has particular experience from international product licensing and research, development- and marketing collaborations as well as from M&A and product acquisitions in the pharmaceutical industry. Anders has presented on collaborations in the industry at conferences arranged by, among others, C5 and IBC. Before Anders joined Lindahl he was the Assistant General Counsel for the AstraZeneca Group's transaction lawyers based outside the U.S. and before that he was the Assistant General Counsel for the Group's lawyers based in Sweden. Previous roles at AstraZeneca as a company lawyer included responsibilities with focus on commercial law and regulatory matters. Between 2007 and 2012 Anders served as Secretary of the Board of AstraZeneca AB and was responsible for company law matters for the Swedish subsidiaries.
Anders advises on a Swedish as well as international level on all types of agreements regarding research, development and commercialisation in the pharmaceutical industry and on questions regarding product approvals, marketing and other regulatory considerations.
- 2013— Lindahl law firm
- 1996-2012 AstraZeneca
- 1994-1996 Sten Lindskog Advokatbyrå
- 1992-1994 Karlskoga District Court